Global comparative analysis of MRSA molecular epidemiology: positioning the Middle East in the global resistance landscape - a systematic review and meta-analysis
Frontiers in Public Health · 20.11.2026 · 14
DOI: 10.3389/fpubh.2026.1958142 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Frontiers in Public Health, online erschienen am 20.11.2026. Verfasst von Nabil A. Nimer. Die Arbeit nennt 126 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Methicillin-resistant Staphylococcus aureus (MRSA) is one of the most important causes of healthcare- and community-associated infections, and the prevalence, circulating clones and resistance patterns differ significantly across regions. This systematic review and meta-analysis compares the molecular epidemiology of MRSA worldwide with specific emphasis on the Middle East, based on published studies of the period 1998–2025.
Methods
This review is carried out based on the PRISMA 2020 guidelines. PubMed, Scopus and the Cochrane Library were searched, supplemented by Google Scholar, for studies published between 1998 and 2025. For the qualitative synthesis, a total of 100 studies were selected, with 22 supplying numerator and denominator data for the quantitative synthesis. Data on prevalence, molecular typing and antimicrobial resistance were extracted to compare regional and global trends in MRSA prevalence and clonal diversity. Pooled prevalence was calculated using random-effects models (R: meta, metafor, ggplot2) and 95% CIs.
Results
The prevalence of MRSA was estimated to be approximately 30% (95% CI = 0.18; 0.44) with high levels of heterogeneity ( I 2 = 98.3%). Regional subgroup analyses revealed the highest prevalence in the Middle East (approximately 50%) and Africa (approximately 45%), followed by Asia and the Americas, with the lowest prevalence in Europe (approximately 12%).
Conclusion
The molecular typing revealed widespread clonal complexes (ST8, ST22, ST239, ST80) with local variation and mecA-mediated β-lactam resistance was the major mechanism. Multidrug resistance was frequently reported, particularly in the Middle East and Africa, whereas vancomycin, teicoplanin and linezolid remained active in nearly all studies that tested them. These findings indicate that MRSA remains a major public health concern and that coordinated global genomic surveillance, antibiotic stewardship, and infection-control measures are needed. The findings highlight the Middle East as a region where multiple globally distributed lineages co-circulate alongside hospital-community hybrid strains. Overall, this analysis improves understanding of global MRSA epidemiology and offers an evidence-based framework for targeted intervention and policymaking.
Zitieren
APA
Nimer, N. A. (2026). Global comparative analysis of MRSA molecular epidemiology: positioning the Middle East in the global resistance landscape - a systematic review and meta-analysis. Frontiers in Public Health, 14. https://doi.org/10.3389/fpubh.2026.1958142
Vancouver
Nimer NA. Global comparative analysis of MRSA molecular epidemiology: positioning the Middle East in the global resistance landscape - a systematic review and meta-analysis. Frontiers in Public Health. 2026;14. doi:10.3389/fpubh.2026.1958142
BibTeX
@article{Nimer2026,
author = {Nimer, Nabil A.},
title = {Global comparative analysis of MRSA molecular epidemiology: positioning the Middle East in the global resistance landscape - a systematic review and meta-analysis},
journal = {Frontiers in Public Health},
year = {2026},
volume = {14},
doi = {10.3389/fpubh.2026.1958142}
}
EUVIMED